Harmony Biosciences Inc. (HRMY)
NASDAQ: HRMY
· Real-Time Price · USD
32.94
-0.03 (-0.09%)
At close: Jun 16, 2025, 3:59 PM
32.96
0.08%
After-hours: Jun 16, 2025, 07:33 PM EDT
-0.09% (1D)
| Bid | 32.5 |
| Market Cap | 1.89B |
| Revenue (ttm) | 744.85M |
| Net Income (ttm) | 152.72M |
| EPS (ttm) | 2.62 |
| PE Ratio (ttm) | 12.57 |
| Forward PE | 8.3 |
| Analyst | Buy |
| Ask | 35.47 |
| Volume | 383,786 |
| Avg. Volume (20D) | 719,749 |
| Open | 33.16 |
| Previous Close | 32.97 |
| Day's Range | 32.69 - 33.42 |
| 52-Week Range | 26.47 - 41.61 |
| Beta | 0.87 |
About HRMY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HRMY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HRMY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-9.64%
Harmony Biosciences shares are trading lower after...
Unlock content with
Pro Subscription
7 months ago
-18.53%
Harmony Biosciences shares are trading lower after the company announced a public offering of up to 8 million shares of common stock by selling shareholders Marshman Fund Trust II and Valor IV Pharma Holdings.
1 month ago · seekingalpha.com
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2025 Earnings Call TranscriptHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY ) Q1 2025 Earnings Call May 6, 2025 8:30 AM ET Company Participants Brennan Doyle - Head, Investor Relations Jeffrey Dayno - President and Chief Executi...
